Carcinoma: all 6,718 studies

Page 49 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.

• Swallowing, Speech and Quality of Life of Patients With Carcinoma of the OropharynxTerminatedNCT02552550
• Neoadjuvant Treatment for Advanced Rectal CarcinomaCompletedNCT02551237Phase 3
• A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell CarcinomaCompletedNCT02550678Phase 1/2
• Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular CarcinomaStatus unknownNCT02550613
• LifePearl-Doxo Pharmacokinetic (PK) StudyCompletedNCT02548780Not applicable
• Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial CarcinomasStatus unknownNCT02547350Phase 2
• PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCCCompletedNCT02544880Phase 1
• A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerTerminatedNCT02543645Phase 1
• SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)CompletedNCT02543476
• Annexin A2 as a Novel Diagnostic Marker in Hepatocellular CarcinomaCompletedNCT02541149
• AMG 319 in HPV Positive and Negative HNSCCTerminatedNCT02540928Phase 2
• A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic CarcinomaCompletedNCT02539537Phase 3
• Comparison of Microwave and Radiofrequency Ablation for LiverCompletedNCT02539212Not applicable
• The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal CarcinomaStatus unknownNCT02537925Phase 3
• Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced Renal Cell CarcinomaCompletedNCT02537743
• Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid TumorsWithdrawnNCT02537561Phase 1
• Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck CancerCompletedNCT02537223Phase 1
• Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung CancerWithdrawnNCT02536495Phase 1/2
• Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial CarcinomaStatus unknownNCT02535650Phase 2
• Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers DiscoveryTerminatedNCT02535351Phase 3
• Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung CancerCompletedNCT02535325Phase 1
• Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCCStatus unknownNCT02535117Phase 4
• Prophylactic Antibiotics Before RFA for HCCStatus unknownNCT02534961Phase 4
• Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular CarcinomaWithdrawnNCT02534337Phase 2/3
• Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate CancerCompletedNCT02532114Phase 1
• A Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction ChemotherapyWithdrawnNCT02531854Phase 2
• Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube CancerWithdrawnNCT02530606Not applicable
• TACE With or Without Sorafenib in Intermediate Stage Hepatocellular CarcinomaStatus unknownNCT02529761Not applicable
• Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular CarcinomaWithdrawnNCT02527772Phase 2/3
• Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal CancerStatus unknownNCT02527057
• Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma PatientsStatus unknownNCT02526953Phase 3
• Laparoscopic Versus Open Liver Resection for Hepatocellular CarcinomaStatus unknownNCT02526043Not applicable
• The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular CarcinomaStatus unknownNCT02525965Not applicable
• Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring SystemStatus unknownNCT02525952Not applicable
• Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT02525380Phase 4
• HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal CarcinomaCompletedNCT02523430Phase 1/2
• HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Cervical CarcinomaCompletedNCT02523365Phase 1/2
• Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma PatientsStatus unknownNCT02523053Not applicable
• Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT02520778Phase 1
• Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian CancerCompletedNCT02520115Phase 1
• Role of FDG PET, Immune and Hypoxic Marker in NSCLCCompletedNCT02519062
• Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous CarcinomaStatus unknownNCT02513342Phase 4
• A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal CarcinomaStatus unknownNCT02512315Phase 3
• Performance of PET 18 F-FDG Coupled to CT With Contrast Injection Iodized in the Diagnosis of Early Recurrences of Head and Neck Carcinoma Treated With Concurrent Chemoradiation. Comparison With 18F-FDG PET Coupled With CT Not Injected With Filling CT Standard InjectionCompletedNCT02510872Not applicable
• Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT02509169Phase 2
• A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular CarcinomaCompletedNCT02508467Phase 1
• WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and NeckCompletedNCT02508246Phase 1
• Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT02507765Phase 1
• Reactivating NK Cells in Treating Refractory Head and Neck CancerStatus unknownNCT02507154Phase 1/2
• Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or SarcomaWithdrawnNCT02507076Not applicable
• Vestibular Function After Chemoradiotherapy for Nasopharyngeal CarcinomaStatus unknownNCT02505672
• Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular CarcinomaStatus unknownNCT02504983Phase 4
• Nasopharyngeal Carcinoma Screening in Zhongshan CityActive, not recruitingNCT02501993
• Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal CarcinomaStatus unknownNCT02500940Phase 3
• Intraoperative Dual-modality Imaging in Renal Cell CarcinomaStatus unknownNCT02497599Phase 1
• Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder CancerTerminatedNCT02494635
• Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma CervixStatus unknownNCT02492503Phase 1/2
• Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell CarcinomaCompletedNCT02489695Phase 2
• Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian CarcinomaActive, not recruitingNCT02487693Phase 2
• DC-CIK Combined With TACE in the Treatment of Hepatocellular CarcinomaStatus unknownNCT02487017Phase 2
• Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)TerminatedNCT02485990Phase 1
• Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)Status unknownNCT02484339Phase 2
• A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular CarcinomaTerminatedNCT02482909Not applicable
• Polymorphisms in Key Genes of Glycolytic Pathway: Influence on Radiosensitivity in Nasopharyngeal CarcinomaStatus unknownNCT02481089
• A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and NeckTerminatedNCT02479178Phase 2
• Serial Plasma EBV DNA for Nasopharyngeal CarcinomaStatus unknownNCT02476669
• A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal CarcinomatosisCompletedNCT02475772Phase 1
• Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast CancerTerminatedNCT02474173Phase 1
• Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCCCompletedNCT02472249Phase 4
• Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or RecurrentWithdrawnNCT02470559Phase 1
• Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)Active, not recruitingNCT02465736Phase 3
• Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal CarcinomaCompletedNCT02460419Phase 3
• A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal CancerCompletedNCT02459457Phase 3
• Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate CancerCompletedNCT02458716Phase 1
• T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesStatus unknownNCT02457650Phase 1
• Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas PatientsCompletedNCT02457273Phase 2
• HR Combined With FOLFOX4 for HCC With PVTTStatus unknownNCT02452853Phase 2
• Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary CancerCompletedNCT02451553Phase 1
• Study for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or SkinTerminatedNCT02449681Phase 2
• Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma RecurrenceCompletedNCT02447679Phase 2
• Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer DiagnosticsStatus unknownNCT02441972Phase 1
• Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT02438995Phase 1
• Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.CompletedNCT02438865Phase 2
• Safety Study of AMG 228 to Treat Solid TumorsTerminatedNCT02437916Phase 1
• Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian CarcinomaStatus unknownNCT02437812Phase 2
• Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial CancerCompletedNCT02437370Phase 1
• Adjuvant Therapies for Patients With HCC and MVIStatus unknownNCT02436902Phase 3
• HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCCApproved for marketingNCT02436044
• The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck CancersCompletedNCT02435602Not applicable
• Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02434614Phase 3
• Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and NeckTerminatedNCT02429089Phase 1
• Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular CarcinomaCompletedNCT02425605Phase 2
• Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPCStatus unknownNCT02421640Phase 2
• Quality of Life in Patients With Hepatocellular CarcinomaStatus unknownNCT02420678
• Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal CarcinomatosisTerminatedNCT02420509
• Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesTerminatedNCT02419495Phase 1
• Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT02418988Phase 2
• Prognostic Significance of Preoperative Hemoglobin A1c (HbA1c) in Renal Cell CarcinomaStatus unknownNCT02417194
• Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic CholangiocarcinomaTerminatedNCT02415036Phase 2
• Genetic Profiling of Liver Cancer in Patients Undergoing Liver TransplantationCompletedNCT02412579

← Carcinoma overview